Upper Gastrointestinal Perforations: a Nationwide Registry-based Study
ConditionAcute Abdomen
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRegion Stockholm
About this trial
The primary aim of this project is to increase the knowledge about how perforations in the esophagus, stomach and small intestine are treated on a national level. Furthermore, secondary aims include assessment of how different treatment options and type of treating facilities relate to patient survival. This will be done by studying information about all adult patients with an upper GI perforation treated in Sweden during 2005-2023.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age of at least 18 years
perforation in either oesophagus, stomach or small intestine
treatment carried out in Sweden
diagnosis set between January 2005 and August 2023
Disqualifiers
children
Trial population
All adult patients with an upper gastrointestinal perforation between 2005-2023 in Sweden.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Surgical treatment type
Procedure/SurgeryThis observational design will study the clinical outcome for each type of upper gastrointestinal perforation in relation to surgical or non-surgery treatment and in relation to treatment centre.
Treatment groups
2,000 Participants
are divided into 3 treatment groupsGroup A: Oesophageal perforation1 intervention
Group B: Gastric perforation1 intervention
Group C: Small intestinal perforation1 intervention
Trial outcomes
Primary outcomes
1
Mortality
Mortality up to one year after diagnosis
Time frame
One year after diagnosisSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: